1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides

  • November 2014
  • -
  • La Merie Publishing
  • -
  • 99 pages

Competitor Analysis: Cancer Peptides


The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.


Therapeutic cancer peptide therapeutics in total represent a considerable market size of more than US$ 8 bln in the year 2013. Major cancer peptide products are of the classes of somatostatin analogs and agonists and antagonists of the gonadotropin releasing hormone (GnRH), but also of targeted cancer therapy including proteasome and HDAC inhibition.


The report provides a compilation of currently major marketed peptide cancer products and active projects in research and development for novel cancer peptides. Competitor projects are listed in a tabular format providing information on:



  • Drug Codes

  • Target / Mechanism of Action

  • Class of Compound

  • Company

  • Product Category

  • Indication,

  • R&D Stage and

  • additional comments with a hyperlink leading to the source of information.


About Competitor Analysis Series:


The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced


Table Of Contents

Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides


Table of Contents:



  • 2013 Sales of Major Cancer Peptides

  • Somatostatin Analogs

  • GnRH Analogs: Agonists

  • GnRH Analogs: Antagonists

  • Targeted Cancer Peptides: Proteasome Inhibition

  • Targeted Cancer Peptides: HDAC Inhibition

  • Cytotoxic, Cytostatic or Apoptotic Cancer Peptides

  • Cancer Peptide-Drug Conjugates and Peptide Fusion Proteins

  • Other Cancer Peptides

  • Corporate Cancer Peptide Randamp;D Pipelines


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • January 2017
    16 pages
  • Therapy  

  • United States  

View report >

Therapy Market in the Netherlands

  • January 2017
    5 pages
  • Therapy  

  • Netherlands  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Diabetes Statistics

2 days ago

Related Market Segments :

Therapy
Cancer
Pharmaceutical

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.